InsidersTradesSigma
Follow the 复旦张江 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 复旦张江 has logged 17 reports. Market capitalisation: €7.5bn. The latest transaction was filed on 10 December 2024 (Sale). Among the most active insiders: 苏勇. The full history is openly available.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
17 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,094 of 29,062 companies
39.0
score / 100
Value37
Quality41
FCF yld1.5%
Earn yld-2.1%
EV/EBITDA·
ROE-6.9%
Gross mgn90%
Net mgn-23%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 December 2024
Declarations17 total
17 of 17 declarations
About 复旦张江
Fudan Zhangjiang is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of innovative drugs.